ArticleProceedings of SPIE--the International Society for Optical Engineering2006
Plasmon-controlled fluorescence: A new detection technology.
Article in Proceedings of SPIE--the International Society for Optical Engineering, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Fluorescence quenching in plasmonic dimers due to electron tunneling.Nanophotonics (Berlin, Germany) · 2022Article
- Nonlinear Optics in Dielectric Guided-Mode Resonant Structures and Resonant Metasurfaces.Micromachines · 2020Review
- Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.Scientific reports · 2017Article
- FOXO3-NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function.Journal of immunology (Baltimore, Md. : 1950) · 2015Article
- Endothelial-like nitric oxide synthase immunolocalization by using gold nanoparticles and dyes.Biomedical optics express · 2015Article
- A single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation.Journal of immunology (Baltimore, Md. : 1950) · 2015Article
- The use of fluorescent quenching in studying the contribution of evaporation to tear thinning.Investigative ophthalmology & visual science · 2012Article
- Strategy for photostable proximity bioassays using lanthanides.Applied optics · 2007Article
- Langmuir-Blodgett monolayers of long-chain NBD derivatives on silver island films: Well-organized probe layer for the metal-enhanced fluorescence studies.The journal of physical chemistry. B · 2006Article
- Saccharide sensing using gold and silver nanoparticles--a review.Journal of fluorescence · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Fluorescence is widely used in biological research. Future advances in biology and medicine often depend on the advances in the capabilities of fluorescence measurements. In this overview paper we describe how a combination of fluorescence, and plasmonics, and nanofabrication can fundamentally change and increase the capabilities of fluorescence technology. This change will be based on the use of surface plasmons which are collective oscillations of free electrons in metallic surfaces and particles. Surface plasmon resonance is now used to measure bioaffinity reactions. However, the uses of surface plasmons in biology are not limited to their optical absorption or extinction. We have shown that fluorophores in the excited state can create plasmons which radiate into the far field; additionally fluorophores in the ground state can interact with and be excited by surface plasmons. These interactions suggest that the novel optical absorption and scattering properties of metallic nanostructures can be used to control the decay rates, location and direction of fluorophore emission. We refer to this technology as plasmon-controlled fluorescence. We predict that plasmon-controlled fluorescence (PCF) will result in a new generation of probes and devices. PCF is likely to allow design of structures which enhance emission at specific wavelengths and the creation of new devices which control and transport the energy from excited fluorophores in the form of plasmons, and then convert the plasmons back to light.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.